UHS Universal Health Services, Inc. Common Stock
NYSE · Health Care · Wyświetl na SEC EDGAR ↗ zamknij Paź 2, 2026 10-K/10-Q Sie 7, 2026UHS Migawka akcji Cena, kapitalizacja rynkowa, P/E, EPS, ROE, zadłużenie/kapitał własny, zakres 52-tygodniowy
UHS Wykres ceny akcji Dzienny OHLCV ze wskaźnikami technicznymi — przesuwaj, powiększaj i dostosowuj widok
Granularność słupków dostosowuje się do wybranego okresu — najedź kursorem na wykres, aby zobaczyć otwarcia/maksima/minima/zamknięcia dla danego słupka.
| Data ex-dywidendy | Podział | Typ |
|---|---|---|
| 16 grudnia 2009 | 2-for-1 | Naprzód |
| 4 czerwca 2001 | 2-for-1 | Naprzód |
| 20 maja 1996 | 2-for-1 | Naprzód |
| 5 lipca 1983 | 2-for-1 | Naprzód |
O Universal Health Services, Inc. Common Stock Przegląd firmy z Wikipedii
Universal Health Services, Inc. (UHS) is an American Fortune 500 company that provides hospital and healthcare services, based in King of Prussia, Pennsylvania. In 2024, UHS reported total revenues of $15.8 billion.
Company history
Alan B. Miller, who currently serves as the company's Executive Chairman, founded Universal Health Services, Inc. in 1979. Within 18 months of its founding, UHS owned four hospitals and had management contracts with two additional hospitals.
In 1979, UHS entered Las Vegas with the purchase of Valley Hospital.
In 1980, the company chose its first Board of Directors. In 1981, UHS held its initial public offering. In 1982, UHS purchased five hospitals from the Stewards Foundation, marking the first time a for-profit corporation purchased hospitals from a nonprofit religious organization. In 1983, UHS purchased Qualicare, Inc. for more than $116 million. The purchase included 11 acute care hospitals and four behavioral health hospitals. In 1986, UHS created Universal Health Realty Income Trust, the first REIT in the healthcare industry.
In 1991, UHS stock trading moved from NASDAQ to NYSE.
In November 2010, UHS reached an agreement in May to acquire Psychiatric Solutions, Inc. for $3.1 billion. In June 2012, UHS announced its plans to acquire Ascend Health Corporation for $517 million. In February 2014, UHS bought Palo Verde Mental Health for an undisclosed amount, renaming the facility to Palo Verde Behavioral Health. In April of that year, UHS announced the acquisition of the Psychiatric Institute of Washington. In September of that year, UHS' stock joined the S&P 500 Index and acquired Cygnet Health Care Limited for approximately $335 million. In August 2015, UHS acquired Alpha Hospitals Holdings Limited for $148 million from private equity group C&C Alpha Group. In September of that year, UHS announced the acquisition of Foundations Recovery Network based in Brentwood, Tennessee for $350 million. In August 2016, UHS bought Desert View Hospital in Pahrump, Nevada for an undisclosed amount. In December of that year, UHS acquired Cambian Group PLC's Adult Services Division. In July 2018, UHS announced its acquisition of the Danshell Group.
On September 28, 2020, Universal Health Services Inc. announced that its network went offline after an unspecified "IT security issue".
In September 2020, consistent with the company's long-standing succession plan, UHS announced that Alan B. Miller would step down as CEO in January 2021 and that President Marc D. Miller would be named CEO.
UHS ranked on the Fortune 500 in 2021, 2022 in 2023 and 2024, and 2025
UHS was named on the Fortune World's Most Admired List in 2025, 2024 2023, 2022, 2021 and 2020.
UHS has been named on the Forbes Global 2000 ranking in 2025. UHS is ranked at #1,090. Of the American companies on the ranking, UHS ranked #355 among U.S. companies and #23 among global Health Care Equipment and Services category. UHS has been on the ranking for 22 years, and in 2023 earned ‘Hall of Fame’ status.
In March 2026, UHS agreed to acquire online and mobile therapy service provider Talkspace for $835 million.
Controversies
Hospital licenses
The Centers for Medicare and Medicaid Services (CMS) threatened the Rancho Springs Medical Center (Murrieta) and Inland Valley Regional Medical Center (Wildomar) in California with decertification in June 2010 while the State of California warned of a possible hospital license revocation. Universal Health Services implemented a program to address all concerns and in November 2011 the two hospitals passed a CMS Certification Survey. As a result, CMS rescinded its termination notice and the California Department of Public Health withdrew its license revocation notice.
Allegations of noncompliance with same-sex visitation law
According to a petition started on Change.org by Terri-Ann Simonelli of Henderson, Nevada, Spring Valley Hospital (owned and operated by UHS) claimed that their policy required power of attorney for a same-sex partner to make medical decisions on behalf of their partner. If true, this would seemingly violate new Department of Health and Human Services rules enabling same-sex partners to make said decisions, with or without power of attorney.
Fraudulent Medicaid claims
In September 2012, UHS and its subsidiaries, Keystone Education and Youth Services LLC and Keystone Marion LLC d/b/a Keystone Marion Youth Center agreed to pay over $6.9 million to resolve allegations that they submitted false and fraudulent claims to Medicaid. Between October 2004 and March 2010, the entities allegedly provided substandard psychiatric counseling and treatment to adolescents in violation of the Medicaid requirements. The United States alleged that UHS falsely represented Keystone Marion Youth Center as a residential treatment facility providing inpatient psychiatric services to Medicaid enrolled children, when in fact it was a juvenile detention facility. The United States further alleged that neither a medical director nor licensed psychiatrist provided the required direction for psychiatric services or for the development of initial or continuing treatment plans. The settlement further resolved allegations that the entities filed false records or statements to Medicaid when they filed treatment plans that falsely represented the level of services that would be provided to the patients.
On July 10, 2020, the US Department of Justice announced a $122 million Fraudulent Claims case with "Universal Health Services, Inc., UHS of Delaware, Inc.(together, UHS), and Turning Point Care Center, LLC (Turning Point), a UHS facility located in Moultrie, Georgia, have agreed to pay a combined total of $122 million to resolve alleged violations of the False Claims Act for billing for medically unnecessary inpatient behavioral health services, failing to provide adequate and appropriate services, and paying illegal inducements to federal healthcare beneficiaries." From the announcement: "The government alleged that, between January 2006, and December 2018, UHS's facilities admitted federal healthcare beneficiaries who were not eligible for inpatient or residential treatment because their conditions did not require that level of care, while also failing to properly discharge appropriately admitted beneficiaries when they no longer required inpatient care. The government further alleged that UHS's facilities billed for services not rendered, billed for improper and excessive lengths of stay, failed to provide adequate staffing, training, and/or supervision of staff, and improperly used physical and chemical restraints and seclusion. In addition, UHS's facilities allegedly failed to develop and/or update individual assessments and treatment plans for patients, failed to provide adequate discharge planning, and failed to provide required individual and group therapy services in accordance with federal and state regulations.
Of the $117 million to be paid by UHS to resolve these claims, the federal government will receive a total of $88,124,761.27, and a total of $28,875,238.73 will be returned to individual states, which jointly fund state Medicaid programs."
BuzzFeed investigation
On December 7, 2016, BuzzFeed published a report detailing questionable practices within UHS psychiatric facilities. The report includes allegations of holding nonthreatening patients against their will, manipulative misinterpretation of patient testimonies to fit guidelines to involuntary confinement, aggressive staff layoffs and understaffing in hospitals, needless patient deaths due to understaffing and misprescription of medication, "violating a patient's right to be discharged or holding a patient without the proper documentation", and unnecessary extension of stay times to the maximum Medicare payout. UHS denied the conclusions of the report. UHS stock fell approximately 12% after publication.
According to BuzzFeed investigative reporter Rosalind Adams, UHS responded to the report by hiring "a global PR firm that offers specialized crisis management services... UHS didn't just implement a crisis PR plan. It also fired an employee that the company believed to have spoken to a reporter; it sued a former employee it alleges leaked damaging internal surveillance videos; it threatened to sue other employees; at least one facility held a series of town hall meetings to warn employees from speaking with us; it conducted "in-depth interviews" with nearly two dozen staff, then distributed a public apology that two of them signed; it enlisted one of the most powerful law firms in the United States; it built multiple, high-production-value websites specifically designed to overcome the reputational damage that our reporting might cause."
Cygnet Healthcare
A UK subsidiary, Cygnet Health Care, was the subject of a BBC investigation that found that staff had been taunting, provoking and scaring vulnerable people. It runs 140 mental health services across the UK. 85% of its services are "rated good or outstanding by our regulators". New admissions were banned at Cygnet Acer clinic after the Care Quality Commission found it unsafe to use. A patient hanged herself, others self harmed, ligature points were found where patients could hang themselves and too many of the staff were untrained to deal with the highly vulnerable patients at the clinic.
The company bought four inpatient units which were previously operated by the Danshell Group in 2018. All four were condemned by the Care Quality Commission which raised concerns about patients' "unexplained injuries" and high levels of restraint in 2019.
Laurel Oaks Behavior Health Center
On February 8, 2024, a lawsuit was filed against the company's Dothan, Alabama-based Laurel Oaks Behavioral Health Center and its CEO Janette Jackson which alleged that Laurel Oaks Behavior Health Center mishandled numerous incidents involving the assault of an eight-year-old boy residing in the facility. The boy was reportedly assaulted by his larger roommate while he residing at the facility for a week in 2022. Universal Health Services would be sued as well. The lawsuit also noted that a 40-year-old man was convicted in 2011 of sexually assaulting a teenage patient while employed at Laurel Oaks. A 17-year-old patient had been charged in 2014 with felony counts of first-degree sodomy as well.
Provo Canyon School
Provo Canyon School was the name two residential treatment centers operated by UHS before being shutdown by the Utah DHHS. The school was in media headlines for years as abuse was prominent throughout its history, including past owners. To name a few allegations, "using a cruel, unusual, or unnecessary practice on a child by withholding personal interaction, emotional response, or stimulation", and "depriving [children] (cilents) of water, rest, and the opportunity for toileting."
Additional allegations
On May 16, 2021, Detroit Free Press published an article alleging UHS partner St. Simons By The Sea (formerly Focus By The Sea) in St. Simons Island, Georgia recruited patients from a local soup kitchen for treatment that may have been coercive or medically unnecessary.(subscription required)
Facilities
Hospitals and medical centers
As of June 2024, the UCS website lists the following medical and acute care facilities in the United States.
California
Corona
Southwest Healthcare Corona Regional Medical Center
Murrieta
A Plus Urgent Care
Southwest Healthcare Rancho Springs Hospital
Temecula Valley Day Surgery
Palmdale
Southwest Healthcare Palmdale Regional Medical Center
Riverside
Riverside Medical Clinic
Temecula
Southwest Healthcare Temecula Valley Hospital
Wildomar
Southwest Healthcare Inland Valley Hospital
District of Columbia
Washington
The George Washington University Hospital
Cedar Hill Hospital Medical Center
Florida
Arcadia
Manatee Diagnostic Center (Arcadia)
Bradenton
ER at Bayshore Gardens
ER at Sun City Center
ER at Palma Sola
Lakewood Ranch Medical Center
Lakewood Ranch Medical Group
Manatee Diagnostic Center (Pointe West)
Manatee Diagnostic Center (Riverside)
Manatee Health
Manatee Memorial Hospital
Manatee Physician Alliance
Orlando
University Behaviorial Center
Parrish
Manatee Diagnostic Center (Parrish)
Royal Palm Beach
Palms Westside Clinic ASC
Sarasota
ER at Fruitville
Wellington
Wellington Physicians Alliance
West Palm Beach
Wellington Regional Medical Center
Westlake
ER at Westlake
Wimauma
ER at Sun City Center
Nevada
Henderson
ER at Green Valley Ranch
Henderson Hospital
Las Vegas
Centennial Hills Hospital Medical Center
Elite Medical Center
ER at Blue Diamond
ER at Desert Springs
ER at West Craig Road
Spring Valley Hospital Medical Center
Summerlin Hospital Medical Center
Valley Health Physician Alliance
Valley Health Specialty Hospital
Valley Hospital Medical Center
North Las Vegas
ER at North Las Vegas
ER at Valley Vista
Pahrump
Desert View Hospital
Reno
ER at Damonte Ranch
ER at McCarran NW
Northern Nevada Sierra Medical Center
Quail Surgical and Pain Management Center
Sparks
ER at Spanish Springs
Northern Nevada Medical Center
Northern Nevada Medical Group
Oklahoma
Enid
St. Mary's Physician Associates
St. Mary's Regional Medical Center
Pennsylvania
King of Prussia
Eastern Pennsylvania Physician Alliance
UHS Corporate
South Carolina
Aiken
Aiken Physicians Alliance
Aiken Regional Medical Centers
Cancer Care Institute of Carolina
The Surgery Center of Aiken
North Augusta
ER at Sweetwater
Texas
Alamo
South Texas Health System ER Alamo
Amarillo
Northwest Emergency at Town Square
Northwest Emergency on Georgia
Northwest Physicians Group
Northwest Texas Healthcare System
Anna
ER at Anna
Bonham
TMC Bonham Hospital
Denison
Texoma Medical Center
TexomaCare
Eagle Pass
Fort Duncan Regional Medical Center
Edinburg
Cornerstone Regional Hospital
South Texas Health System Edinburg / South Texas Health System Children's
South Texas Health System ER McColl
South Texas Health System ER Monte Cristo
Laredo
Doctors Hospital Emergency Room Saunders
Doctors Hospital Emergency Room South
Doctors Hospital of Laredo
Laredo Physicians Group
McAllen
South Texas Health System Clinics
South Texas Health System ER Ware Road
South Texas Health System Heart
South Texas Health System McAllen
Mission
South Texas Health System ER Mission
Sherman
ER at Sherman
Weslaco
South Texas Health System ER Weslaco
Behavioral health facilities
UHS also operates over 300 behavioral health facilities in the United States and the United Kingdom, including:
Cygnet Health Care, UK
Psychiatric Institute of Washington, Washington, District of Columbia
Suncoast Behavioral Health Center, Bradenton, Florida
Fuller Hospital, South Attleboro, Massachusetts
Willow Springs Center, Reno, Nevada
Friends Hospital, Philadelphia, Pennsylvania
Provo Canyon School, Provo, Utah
Lancaster Behavioral Health Hospital, Lancaster, PA
Źródło: Wikipedia (Angielski), CC BY-SA 4.0 · Zobacz w Wikipedii ↗
Wyniki 10-letnie Trendy przychodów, zysku netto, marż i EPS
Wycena Wskaźniki P/E, P/S, P/B, EV/EBITDA — czy akcje są drogie, czy tanie?
| Wskaźnik | Trend 5-letni | UHS | średnia z 5 lat | Mediana porównawcza | Werdykt |
|---|---|---|---|---|---|
| P/E (TTM) | 7.2średnia z 5 lat ≈11.7 | ≈11.7 | 16.5 | Niedowartościowany | |
| PEG Ratio (Współczynnik PEG) | ≈0.4 | · | · | · |
Mediana porównawcza jest obliczana na znormalizowanej podstawie dla każdej metryki i może nie zawsze odpowiadać podstawie TTM/MRQ pokazanej dla tej akcji.
Rentowność Marże brutto, operacyjne i netto; ROE, ROA, ROIC
| Wskaźnik | Trend 5-letni | UHS | średnia z 5 lat | Mediana porównawcza | Werdykt |
|---|---|---|---|---|---|
| Marża Operacyjna (TTM) | 11.4%średnia z 5 lat ≈10.1% | ≈10.1% | 11.9% | Słaby | |
| EBITDA Margin (Marża EBITDA) | 11.5%średnia z 5 lat ≈10.1% | ≈10.1% | 11.1% | Zgodnie z | |
| Marża przed opodatkowaniem (TTM) | 11.2%średnia z 5 lat ≈9.1% | ≈9.1% | 9.8% | Zgodnie z | |
| Marża Zysku Netto (TTM) | 8.4%średnia z 5 lat ≈6.9% | ≈6.9% | 7.3% | Zgodnie z | |
| ROA (TTM) | 9.9%średnia z 5 lat ≈7.7% | ≈7.7% | 6.5% | Najwyższa półka | |
| ROE (TTM) | 21.0%średnia z 5 lat ≈17.0% | ≈17.0% | 19.1% | Zgodnie z | |
| ROIC | 12.7%średnia z 5 lat ≈10.8% | ≈10.8% | 13.5% | Słaby |
Zdrowie finansowe Dług, płynność, wypłacalność — siła bilansu
| Wskaźnik | Trend 5-letni | UHS | średnia z 5 lat | Mediana porównawcza | Werdykt |
|---|---|---|---|---|---|
| Dług / Kapitał Własny (MRQ) | 0.6średnia z 5 lat ≈0.7 | ≈0.7 | 0.2 | Wysokie zadłużenie | |
| Wskaźnik bieżący (MRQ) | 1.1średnia z 5 lat ≈1.2 | ≈1.2 | 1.2 | Niska płynność | |
| Quick Ratio (Wskaźnik Szybkości) | 0.8średnia z 5 lat ≈1.0 | ≈1.0 | 0.9 | Zgodnie z | |
| Dług długoterminowy / Kapitał własny (MRQ) | 0.5średnia z 5 lat ≈0.7 | ≈0.7 | 0.2 | Wysokie zadłużenie | |
| Interest Coverage (Pokrycie odsetek) | 12.8średnia z 5 lat ≈9.2 | ≈9.2 | 7.8 | Silna płynność |
Rozwój Wzrost przychodów, EPS i zysku netto: r/r, CAGR 3-letni, CAGR 5-letni
| Wskaźnik | Trend 5-letni | UHS | średnia z 5 lat | Mediana porównawcza | Werdykt |
|---|---|---|---|---|---|
| Revenue YoY (Przychody R/R) | 9.7%średnia z 5 lat ≈9.0% | ≈9.0% | · | · | |
| Revenue CAGR 3Y (Przychody CAGR 3L) | 9.0%średnia z 5 lat ≈8.0% | ≈8.0% | · | · | |
| Revenue CAGR 5Y (Przychody CAGR 5L) | 8.5% | · | · | · | |
| EPS YoY | 37.3%średnia z 5 lat ≈37.9% | ≈37.9% | · | · | |
| Net Income YoY (Zysk Netto R/R) | 30.4%średnia z 5 lat ≈31.9% | ≈31.9% | · | · | |
| EPS CAGR 3Y (CAGR z EPS 3 lata) | 36.2%średnia z 5 lat ≈15.4% | ≈15.4% | · | · | |
| EPS CAGR 5Y (CAGR z EPS 5 lat) | 16.0% | · | · | · | |
| Net Income CAGR 3Y (CAGR z zysku netto 3 lata) | 30.1%średnia z 5 lat ≈8.7% | ≈8.7% | · | · | |
| Net Income CAGR 5Y (CAGR z zysku netto 5 lat) | 9.5% | · | · | · |
Efektywność kapitałowa Rotacja aktywów, rotacja zapasów, rotacja należności
| Wskaźnik | Trend 5-letni | UHS | średnia z 5 lat | Mediana porównawcza | Werdykt |
|---|---|---|---|---|---|
| Asset Turnover (Rotacja aktywów) | 1.2średnia z 5 lat ≈1.1 | ≈1.1 | 0.8 | Najwyższa półka | |
| Receivables Turnover (Rotacja należności) | 7.3średnia z 5 lat ≈7.0 | ≈7.0 | 8.4 | Słaby | |
| Revenue / Employee (Przychody / pracownika) | ≈$170.2K | · | · | · |
wartość · ≈ średnia z 5 lat · mediana branżowa · werdykt względem mediany
Dywidendy Stopa dywidendy, wskaźnik wypłaty, historia dywidend, 5-letni CAGR
| Data ex-dywidendy | Kwota | Waluta | Stopa zwrotu |
|---|---|---|---|
| Wrz 1, 2026 | $0,20 | USD | ≈0.47% |
| Cze 8, 2026 | $0,20 | USD | ≈0.56% |
| Mar 2, 2026 | $0,20 | USD | ≈0.39% |
| Gru 1, 2025 | $0,20 | USD | ≈0.33% |
| Wrz 2, 2025 | $0,20 | USD | ≈0.44% |
| Cze 2, 2025 | $0,20 | USD | ≈0.43% |
| Mar 3, 2025 | $0,20 | USD | ≈0.46% |
| Gru 3, 2024 | $0,20 | USD | ≈0.40% |
| Wrz 3, 2024 | $0,20 | USD | ≈0.34% |
| Cze 3, 2024 | $0,20 | USD | ≈0.43% |
| Lut 29, 2024 | $0,20 | USD | ≈0.48% |
| Lis 30, 2023 | $0,20 | USD | ≈0.58% |
| Sie 31, 2023 | $0,20 | USD | ≈0.59% |
| Maj 31, 2023 | $0,20 | USD | ≈0.61% |
| Lut 28, 2023 | $0,20 | USD | ≈0.60% |
| Lis 30, 2022 | $0,20 | USD | ≈0.61% |
| Sie 31, 2022 | $0,20 | USD | ≈0.82% |
| Maj 31, 2022 | $0,20 | USD | ≈0.64% |
| Lut 28, 2022 | $0,20 | USD | ≈0.56% |
| Lis 30, 2021 | $0,20 | USD | ≈0.67% |
Historia zysków EPS faktyczny vs szacowany, zaskoczenie %, wskaźnik trafień, data następnych wyników
| Okres | Raport | EPS Actual | EPS Szacowany | Niespodzianka |
|---|---|---|---|---|
| 30 czerwca 2026 | Lip 27, 2026 | $5.98 | $6.02 | -0.61% |
| 31 marca 2026 | $5.62 | $5.46 | 2.9% | |
| 31 grudnia 2025 | $5.88 | $5.96 | -1.3% | |
| 30 września 2025 | $5.69 | $4.88 | 16.5% | |
| 30 czerwca 2025 | $5.35 | $4.97 | 7.6% | |
| 31 marca 2025 | $4.84 | $4.39 | 10.2% |
Pełne podstawowe wskaźniki Wszystkie wskaźniki roczne — rachunek zysków i strat, bilans, przepływy pieniężne
Rachunek zysków i strat
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $17.36B | $15.83B | $14.28B | $13.40B | $12.64B | $11.56B | $11.38B | $10.77B | $10.41B | $9.77B | $9.04B | $8.21B | |
| Operating Expenses | $15.37B | $14.15B | $13.11B | $12.40B | $11.28B | $10.20B | $10.16B | $9.60B | $9.13B | $8.48B | $7.78B | $7.14B | |
| Operating Income | $1.99B | $1.68B | $1.18B | $1.00B | $1.36B | $1.36B | $1.22B | $1.18B | $1.28B | $1.28B | $1.26B | $1.06B | |
| Interest Expense | $156M | $186M | $207M | $127M | $84M | $106M | $163M | $155M | $145M | $125M | $113M | $134M | |
| Other Non-op | $134M | $2M | $-28M | $-10M | $14M | $14.0K | $13M | $14M | $0 | $0 | · | · | |
| Pretax Income | $1.97B | $1.50B | $940M | $866M | $1.29B | $1.25B | $1.07B | $1.03B | $1.14B | $1.16B | $1.15B | $930M | |
| Income Tax | $461M | $335M | $221M | $209M | $306M | $299M | $239M | $237M | $364M | $409M | $395M | $325M | |
| Net Income | $1.49B | $1.14B | $718M | $676M | $992M | $944M | $815M | $780M | $752M | $702M | $681M | $545M | |
| EPS (Basic) | $23.42 | $17.16 | $10.35 | $9.23 | $11.99 | $11.06 | $9.16 | $8.35 | $7.86 | $7.22 | $6.89 | $5.52 | |
| EPS (Diluted) | $23.10 | $16.82 | $10.23 | $9.14 | $11.82 | $10.99 | $9.13 | $8.31 | $7.81 | $7.14 | $6.76 | $5.42 | |
| Shares (Basic) | 63,581,000 | 66,554,000 | 69,321,000 | 73,118,000 | 82,519,000 | 85,061,000 | 88,762,000 | 93,276,000 | 95,652,000 | 97,208,000 | 98,797,000 | 98,826,000 | |
| Shares (Diluted) | 64,462,000 | 67,896,000 | 70,125,000 | 73,832,000 | 83,692,000 | 85,587,000 | 89,040,000 | 93,750,000 | 96,325,000 | 98,380,000 | 100,694,000 | 100,544,000 | |
| EBITDA | $1.99B | $1.68B | $1.18B | $1.00B | $1.36B | $1.36B | $1.22B | $1.18B | $1.28B | $1.28B | $1.66B | $1.44B |
Bilans
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $138M | $126M | $119M | $103M | $115M | $1.22B | $61M | $105M | $74M | $34M | $61M | $32M | |
| Receivables | $2.60B | $2.18B | $2.24B | $2.02B | $1.75B | $1.73B | $1.56B | $1.51B | $1.50B | $1.44B | $1.30B | $1.28B | |
| Other Current Assets | $436M | $292M | $237M | $198M | $195M | $138M | $134M | $174M | $87M | $83M | $103M | $78M | |
| Current Assets | $3.41B | $2.82B | $2.81B | $2.54B | $2.26B | $3.28B | $1.92B | $1.94B | $1.80B | $1.68B | $1.72B | $1.62B | |
| PP&E (Net) | $7.01B | $6.57B | $6.12B | $5.92B | $5.87B | $5.37B | $5.02B | $4.85B | $4.57B | $4.33B | $3.84B | $3.68B | |
| PP&E (Gross) | $13.49B | $12.64B | $11.78B | $11.09B | $10.77B | $9.89B | $9.11B | $8.56B | $7.92B | $7.31B | $6.53B | $6.21B | |
| Accum. Depreciation | $6.48B | $6.07B | $5.65B | $5.17B | $4.90B | $4.51B | $4.09B | $3.72B | $3.35B | $2.98B | $2.69B | $2.53B | |
| Goodwill | $3.99B | $3.93B | $3.93B | $3.91B | $3.96B | $3.88B | $3.87B | $3.84B | $3.83B | $3.78B | $3.60B | $3.29B | |
| Intangibles | $76M | $76M | $77M | $78M | $81M | $83M | $84M | $173M | $220M | $228M | $219M | $98M | |
| Other Non-current Assets | $5.11B | $5.08B | $5.03B | $5.04B | $4.96B | $4.82B | $4.74B | $4.48B | $4.39B | $4.31B | $4.06B | $3.68B | |
| Total Assets | $15.53B | $14.47B | $13.97B | $13.49B | $13.09B | $13.48B | $11.67B | $11.27B | $10.76B | $10.32B | $9.62B | $8.95B | |
| Accounts Payable | $750M | $632M | $614M | $637M | $659M | $571M | $447M | $446M | $442M | $440M | $366M | $336M | |
| Current Liabilities | $3.24B | $2.21B | $2.01B | $1.91B | $1.98B | $2.48B | $1.56B | $1.45B | $1.85B | $1.32B | $1.10B | $1.18B | |
| Capital Leases | $341M | $376M | $383M | $396M | $305M | $278M | $270M | $18M | $20M | $22M | $23M | · | |
| Deferred Tax | $6M | $0 | · | · | $0 | $6M | $25M | $50M | $55M | $88M | $316M | $168M | |
| Other Non-current Liabilities | $528M | $656M | $584M | $488M | $465M | $459M | $330M | $362M | $306M | $275M | $279M | $269M | |
| Long-term Debt | $4.80B | $4.50B | $4.91B | $4.81B | $4.19B | $3.86B | $3.98B | $4.00B | $4.04B | $4.14B | $3.43B | $3.28B | |
| Total Debt | $4.75B | $4.50B | $4.91B | $4.81B | $4.19B | $3.86B | $3.98B | $4.00B | $4.04B | $4.14B | $3.45B | $3.28B | |
| Retained Earnings | $7.99B | $7.37B | $6.80B | $6.53B | $6.60B | $6.75B | $5.93B | $5.79B | $5.35B | $4.89B | $4.57B | $4.02B | |
| AOCI | $48M | $7M | $9M | $-10M | $30M | $48M | $32M | $4M | $7M | $-25M | $-23M | $-25M | |
| Stockholders' Equity | $7.28B | $6.67B | $6.15B | $5.92B | $6.09B | $6.32B | $5.50B | $5.39B | $4.99B | $4.53B | $4.25B | $3.74B | |
| Liabilities + Equity | $15.53B | $14.47B | $13.97B | $13.49B | $13.09B | $13.48B | $11.67B | $11.27B | $10.76B | $10.32B | $9.62B | $8.97B |
Przepływy pieniężne
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $619M | $585M | $568M | $582M | $533M | $510M | $490M | $453M | $448M | $417M | $399M | $376M | |
| Stock-based Comp | $96M | $99M | $88M | $85M | $74M | $66M | $69M | $67M | $57M | $48M | $40M | $31M | |
| Deferred Tax | $51M | $-33M | $-18M | $-18M | $-30M | $-27M | $-36M | $-10M | $-37M | $-10M | $-11M | $49M | |
| Other Non-cash | · | · | · | · | · | · | · | · | · | · | $-88M | $35M | |
| Operating Cash Flow | $1.86B | $2.07B | $1.27B | $996M | $884M | $2.36B | $1.44B | $1.27B | $1.25B | $1.33B | $1.07B | $1.04B | |
| CapEx | $1.02B | $944M | $743M | $734M | $856M | $731M | $634M | $665M | $558M | $520M | $379M | $391M | |
| Investing Cash Flow | $-1.07B | $-911M | $-763M | $-647M | $-914M | $-803M | $-688M | $-747M | $-685M | $-1.16B | $-913M | $-833M | |
| Net Debt Issued | $-44M | $-2.64B | $-85M | $-89M | $-3.04B | $-963M | $-57M | $-830M | $-143M | $-459M | $-68M | $-879M | |
| Stock Issued | $17M | $15M | $14M | $14M | $13M | $12M | $11M | $10M | $10M | $10M | $8M | $7M | |
| Stock Repurchased | $968M | $671M | $547M | $833M | $1.22B | $207M | $771M | $397M | $364M | $353M | $210M | $101M | |
| Net Stock Activity | $-951M | $-656M | $-534M | $-819M | $-1.21B | $-194M | $-760M | $-387M | $-354M | $-344M | $-201M | $-94M | |
| Dividends Paid | $51M | $53M | $55M | $58M | $66M | $17M | $53M | $37M | $38M | $39M | $40M | $30M | |
| Financing Cash Flow | $-750M | $-1.14B | $-494M | $-318M | $-1.07B | $-385M | $-845M | $-492M | $-519M | $-171M | $-125M | $-187M | |
| Net Change in Cash | $47M | $10M | $14M | $22M | $-1.10B | $1.17B | $-94M | $32M | $45M | $5M | $29M | $15M | |
| Taxes Paid | $471M | $325M | $258M | $251M | $363M | $286M | $261M | $294M | $371M | $345M | $381M | $259M | |
| Free Cash Flow | $849M | $1.12B | $525M | $262M | $28M | $1.63B | $804M | $676M | $625M | $769M | $642M | $645M | |
| Levered FCF | $730M | $979M | $367M | $166M | $-36M | $1.55B | $678M | $556M | $526M | $688M | $567M | $558M |
Rentowność
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | 11.5% | 10.6% | 8.2% | 7.5% | 10.8% | 11.8% | 10.7% | 10.9% | 12.3% | 13.1% | 13.9% | 13.2% | |
| Net Margin | 8.6% | 7.2% | 5.0% | 5.0% | 7.8% | 8.2% | 7.2% | 7.2% | 7.2% | 7.2% | 7.5% | 6.8% | |
| Pretax Margin | 11.4% | 9.5% | 6.6% | 6.5% | 10.2% | 10.8% | 9.4% | 9.6% | 10.9% | 11.8% | 12.7% | 11.5% | |
| EBITDA Margin | 11.5% | 10.6% | 8.2% | 7.5% | 10.8% | 11.8% | 10.7% | 10.9% | 12.3% | 13.1% | 18.3% | 17.8% | |
| ROA | 9.9% | 8.0% | 5.2% | 5.0% | 7.6% | 7.1% | 7.0% | 6.9% | 7.0% | 7.0% | 7.2% | 6.1% | |
| ROE | 21.4% | 17.8% | 11.9% | 11.2% | 16.0% | 16.0% | 15.0% | 15.0% | 15.8% | 16.0% | 17.0% | 15.6% | |
| ROIC | 12.7% | 11.7% | 8.1% | 7.1% | 10.1% | 10.2% | 10.0% | 9.7% | 9.6% | 9.6% | 10.7% | 9.9% |
Płynność i wypłacalność
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.1 | 1.3 | 1.4 | 1.3 | 1.1 | 1.3 | 1.2 | 1.3 | 1.0 | 1.3 | 1.6 | 1.4 | |
| Quick Ratio | 0.8 | 1.0 | 1.2 | 1.1 | 0.9 | 1.2 | 1.0 | 1.1 | 0.9 | 1.1 | 1.2 | 1.1 | |
| Debt / Equity | 0.7 | 0.7 | 0.8 | 0.8 | 0.7 | 0.6 | 0.7 | 0.7 | 0.8 | 0.9 | 0.8 | 0.9 | |
| LT Debt / Equity | 0.6 | 0.7 | 0.8 | 0.8 | 0.7 | 0.6 | 0.7 | 0.7 | 0.7 | 0.9 | 0.8 | 0.9 | |
| Interest Coverage | 12.8 | 9.0 | 5.7 | 7.9 | 16.3 | 12.8 | 7.5 | 7.6 | 8.8 | 10.2 | 11.1 | 8.0 |
Efektywność
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 1.2 | 1.1 | 1.0 | 1.0 | 1.0 | 0.9 | 1.0 | 1.0 | 1.0 | 1.0 | 1.0 | 0.9 | |
| Receivables Turnover | 7.3 | 7.2 | 6.7 | 7.1 | 7.3 | 7.0 | 7.4 | 7.2 | 7.1 | 7.1 | 7.0 | 6.7 |
Na akcję
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue / Share | $269.38 | $233.12 | $203.66 | $181.48 | $151.06 | $135.05 | $127.79 | $114.90 | $108.07 | $99.27 | $89.81 | $80.22 | |
| Cash Flow / Share | $28.92 | $30.45 | $18.08 | $13.49 | $10.56 | $27.58 | $16.16 | $14.30 | $12.28 | $13.10 | $10.14 | $10.30 | |
| Dividend Paid / Share | $0.80 | $0.80 | $0.80 | $0.80 | $0.80 | · | $0.60 | $0.40 | · | · | · | $0.30 | |
| EPS (TTM) | $23.10 | $16.82 | $10.23 | $9.14 | $11.82 | $10.99 | $9.13 | $8.31 | $7.81 | $7.14 | $6.76 | $5.42 |
Stopy Wzrostu
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 9.7% | 10.8% | 6.6% | 6.0% | 9.4% | · | · | · | · | · | · | · | |
| Revenue CAGR 3Y | 9.0% | 7.8% | 7.3% | · | · | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | 8.5% | · | · | · | · | · | · | · | · | · | · | · | |
| EPS YoY | 37.3% | 64.4% | 11.9% | -22.7% | 7.5% | · | · | · | · | · | · | · | |
| EPS CAGR 3Y | 36.2% | 12.5% | -2.4% | · | · | · | · | · | · | · | · | · | |
| EPS CAGR 5Y | 16.0% | · | · | · | · | · | · | · | · | · | · | · | |
| Net Income YoY | 30.4% | 59.1% | 6.2% | -31.9% | 5.1% | · | · | · | · | · | · | · | |
| Net Income CAGR 3Y | 30.1% | 4.8% | -8.7% | · | · | · | · | · | · | · | · | · | |
| Net Income CAGR 5Y | 9.5% | · | · | · | · | · | · | · | · | · | · | · | |
| Dividends Paid CAGR 5Y | 24.2% | · | · | · | · | · | · | · | · | · | · | · |
Wycena (TTM)
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $17.36B | $15.83B | $14.28B | $13.40B | $12.64B | $11.56B | $11.38B | $10.77B | $10.41B | $9.77B | $9.04B | $8.21B | |
| Net Income TTM | $1.49B | $1.14B | $718M | $676M | $992M | $944M | $815M | $780M | $752M | $702M | $681M | $545M | |
| P/E | 9.4 | 10.7 | 14.9 | 15.4 | 11.0 | 12.5 | 15.7 | 14.0 | 14.5 | 14.9 | 17.7 | 20.5 | |
| Earnings Yield | 10.6% | 9.4% | 6.7% | 6.5% | 9.1% | 8.0% | 6.4% | 7.1% | 6.9% | 6.7% | 5.7% | 4.9% | |
| Payout Ratio | 3.4% | 4.7% | 7.7% | 8.6% | 6.7% | 1.8% | 6.5% | 4.8% | 5.1% | 5.5% | 5.8% | 5.4% | |
| Annual Payout | $51M | $53M | $55M | $58M | $66M | $17M | $53M | $37M | $38M | $39M | $40M | $30M |
Rachunek zysków i strat
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $4.64B | $4.50B | $4.49B | $4.50B | $4.28B | $4.10B | $4.11B | $3.96B | $3.91B | $3.84B | $3.70B | $3.56B | $3.55B | $3.47B | $3.45B | $3.34B | |
| Operating Expenses | $4.12B | $3.99B | $3.97B | $3.97B | $3.78B | $3.64B | $3.64B | $3.58B | $3.47B | $3.45B | $3.37B | $3.28B | $3.27B | $3.19B | $3.19B | $3.06B | |
| Operating Income | $517M | $503M | $517M | $522M | $500M | $455M | $472M | $384M | $436M | $389M | $331M | $285M | $280M | $279M | $261M | $276M | |
| Interest Expense | $40M | $37M | $42M | $38M | $35M | $40M | $40M | $45M | $49M | $53M | $54M | $53M | $49M | $51M | $44M | $36M | |
| Other Non-op | $2M | $3M | $106M | $14M | $8M | $6M | $6M | $2M | $-5M | $150.0K | $4M | $-11M | $-7M | $-14M | $5M | $-6M | |
| Pretax Income | $479M | $469M | $581M | $497M | $473M | $420M | $438M | $342M | $382M | $336M | $281M | $221M | $225M | $214M | $222M | $234M | |
| Income Tax | $115M | $110M | $134M | $118M | $111M | $99M | $101M | $76M | $88M | $70M | $62M | $52M | $55M | $52M | $52M | $57M | |
| Net Income | $358M | $349M | $446M | $373M | $353M | $317M | $332M | $259M | $289M | $262M | $216M | $167M | $171M | $163M | $175M | $183M | |
| EPS (Basic) | $6.01 | $5.71 | $7.14 | $5.92 | $5.49 | $4.87 | $5.05 | $3.89 | $4.32 | $3.90 | $3.18 | $2.42 | $2.44 | $2.31 | $2.44 | $2.52 | |
| EPS (Diluted) | $5.98 | $5.65 | $7.01 | $5.86 | $5.43 | $4.80 | $4.94 | $3.80 | $4.26 | $3.82 | $3.13 | $2.40 | $2.42 | $2.28 | $2.42 | $2.50 | |
| Shares (Basic) | 59,657,000 | 61,071,000 | · | 62,974,000 | 64,356,000 | 64,970,000 | · | 66,537,000 | 66,878,000 | 67,204,000 | · | 68,867,000 | 70,073,000 | 70,535,000 | · | 72,595,000 | |
| Shares (Diluted) | 59,910,000 | 61,668,000 | · | 63,663,000 | 64,991,000 | 66,037,000 | · | 68,108,000 | 67,920,000 | 68,482,000 | · | 69,624,000 | 70,839,000 | 71,487,000 | · | 73,060,000 | |
| EBITDA | $517M | $503M | · | $522M | $500M | $455M | · | $384M | $436M | $389M | · | $285M | $280M | $279M | · | $276M |
Bilans
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $139M | $119M | $138M | $113M | $138M | $127M | $126M | $106M | $129M | $112M | $119M | $81M | $79M | $110M | $103M | $75M | |
| Receivables | $2.80B | $2.75B | $2.60B | $2.59B | $2.30B | $2.41B | $2.18B | $2.21B | $2.16B | $2.30B | · | $2.23B | $2.10B | $2.03B | · | $1.90B | |
| Other Current Assets | $505M | $406M | $436M | $333M | $327M | $317M | $292M | $262M | $236M | $243M | · | $223M | $226M | $201M | · | $262M | |
| Current Assets | $3.68B | $3.50B | $3.41B | $3.26B | $2.99B | $3.08B | $2.82B | $2.80B | $2.74B | $2.87B | · | $2.75B | $2.62B | $2.56B | · | $2.46B | |
| PP&E (Net) | $7.14B | $7.06B | $7.01B | $6.97B | $6.88B | $6.70B | $6.57B | $6.44B | $6.33B | $6.18B | · | $6.09B | $6.03B | $5.95B | · | $5.94B | |
| PP&E (Gross) | $13.83B | $13.61B | · | $13.45B | $13.24B | $12.91B | · | $12.45B | $12.24B | $11.96B | · | $11.61B | $11.44B | $11.25B | · | $11.10B | |
| Accum. Depreciation | $6.69B | $6.55B | $6.48B | $6.48B | $6.35B | $6.21B | $6.07B | $6.01B | $5.91B | $5.77B | · | $5.52B | $5.41B | $5.30B | · | $5.17B | |
| Goodwill | $3.98B | $3.98B | $3.99B | $3.99B | $3.98B | $3.95B | $3.93B | $3.97B | $3.94B | $3.93B | $3.93B | $3.91B | $3.93B | $3.91B | $3.91B | $3.87B | |
| Intangibles | · | · | $76M | · | · | · | $76M | · | · | · | · | · | · | · | · | · | |
| Other Non-current Assets | · | · | $5.11B | · | · | · | $5.08B | · | · | · | · | · | · | · | · | · | |
| Total Assets | $15.94B | $15.68B | $15.53B | $15.34B | $14.99B | $14.88B | $14.47B | $14.35B | $14.07B | $14.05B | · | $13.87B | $13.73B | $13.56B | · | $13.38B | |
| Accounts Payable | · | · | $750M | · | · | · | $632M | · | · | · | · | · | · | · | · | · | |
| Current Liabilities | $3.30B | $3.24B | $3.24B | $3.16B | $2.32B | $2.33B | $2.21B | $2.01B | $2.15B | $2.08B | · | $1.99B | $2.04B | $1.86B | · | $1.94B | |
| Capital Leases | $339M | $345M | $341M | $346M | $352M | $369M | $376M | $378M | $380M | $374M | · | $389M | $388M | $396M | · | $393M | |
| Deferred Tax | $3M | $3M | $6M | · | · | · | $0 | · | · | · | · | · | · | · | · | · | |
| Other Non-current Liabilities | $560M | $533M | $528M | $590M | $629M | $682M | $656M | $660M | $570M | $551M | · | $588M | $571M | $532M | · | $500M | |
| Long-term Debt | $4.90B | $4.70B | $4.75B | $4.70B | $4.60B | $4.60B | $4.50B | $4.70B | $4.50B | $4.90B | · | $4.90B | $4.70B | $4.80B | · | $4.70B | |
| Total Debt | $4.85B | $4.71B | · | $4.69B | $4.58B | $4.65B | · | $4.66B | $4.54B | $4.86B | · | $4.92B | $4.72B | $4.80B | · | $4.70B | |
| Retained Earnings | · | · | $7.99B | · | · | · | $7.37B | · | · | · | · | · | · | · | · | · | |
| AOCI | · | · | $48M | · | · | · | $7M | · | · | · | · | · | · | · | · | · | |
| Stockholders' Equity | $7.51B | $7.46B | $7.28B | $7.17B | $7.03B | $6.79B | $6.67B | $6.61B | $6.49B | $6.26B | · | $6.06B | $6.09B | $6.01B | · | $5.86B | |
| Liabilities + Equity | $15.94B | $15.68B | $15.53B | $15.34B | $14.99B | $14.88B | $14.47B | $14.35B | $14.07B | $14.05B | · | $13.87B | $13.73B | $13.56B | · | $13.38B |
Przepływy pieniężne
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $167M | $155M | $163M | $155M | $152M | $148M | $147M | $150M | $147M | $141M | $145M | $137M | $144M | $142M | $148M | $146M | |
| Stock-based Comp | $23M | $23M | $25M | $25M | $24M | $22M | $27M | $27M | $27M | $20M | $22M | $23M | $22M | $21M | $23M | $21M | |
| Operating Cash Flow | $443M | $402M | $575M | $381M | $549M | $360M | $658M | $333M | $679M | $396M | $452M | $162M | $363M | $291M | $297M | $221M | |
| CapEx | $228M | $217M | $281M | $229M | $266M | $239M | $246M | $248M | $241M | $209M | $206M | $200M | $168M | $169M | $164M | $162M | |
| Investing Cash Flow | $-234M | $-198M | $-224M | $-269M | $-306M | $-271M | $-208M | $-266M | $-243M | $-195M | $-239M | $-176M | $-170M | $-178M | $-248M | $-73M | |
| Net Debt Issued | · | $-45M | · | · | · | $-9M | · | · | · | $-64M | · | · | · | $-16M | · | · | |
| Stock Issued | $5M | $4M | $5M | $4M | $4M | $4M | $4M | $4M | $4M | $3M | $4M | $3M | $4M | $3M | $4M | $4M | |
| Stock Repurchased | $321M | $164M | $352M | $237M | $155M | $223M | $250M | $183M | $96M | $142M | $162M | $176M | $125M | $85M | $110M | $158M | |
| Net Stock Activity | · | $-160M | · | · | · | $-220M | · | · | · | $-139M | · | · | · | $-82M | · | · | |
| Dividends Paid | $12M | $13M | $12M | $12M | $13M | $14M | $13M | $13M | $13M | $14M | $14M | $14M | $14M | $14M | $14M | $15M | |
| Financing Cash Flow | $-189M | $-222M | $-296M | $-135M | $-228M | $-91M | $-427M | $-90M | $-420M | $-209M | $-182M | $18M | $-224M | $-106M | $-15M | $-179M | |
| Net Change in Cash | $20M | $-19M | $55M | $-25M | $18M | $-1M | $20M | $-19M | $17M | $-8M | $34M | $1M | $-30M | $8M | $35M | $-37M | |
| Taxes Paid | $189M | $8M | $115M | $104M | $246M | $6M | $88M | $105M | $129M | $3M | $67M | $57M | $131M | $2M | $69M | $37M | |
| Free Cash Flow | · | $184M | · | · | · | $121M | · | · | · | $188M | · | · | · | $122M | · | · | |
| Levered FCF | · | $156M | · | · | · | $90M | · | · | · | $146M | · | · | · | $83M | · | · |
Rentowność
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | 11.1% | 11.2% | · | 11.6% | 11.7% | 11.1% | · | 9.7% | 11.2% | 10.1% | · | 8.0% | 7.9% | 8.0% | · | 8.3% | |
| Net Margin | 7.7% | 7.8% | · | 8.3% | 8.2% | 7.7% | · | 6.5% | 7.4% | 6.8% | · | 4.7% | 4.8% | 4.7% | · | 5.5% | |
| Pretax Margin | 10.3% | 10.4% | · | 11.1% | 11.1% | 10.3% | · | 8.6% | 9.8% | 8.7% | · | 6.2% | 6.3% | 6.2% | · | 7.0% | |
| EBITDA Margin | 11.1% | 11.2% | · | 11.6% | 11.7% | 11.1% | · | 9.7% | 11.2% | 10.1% | · | 8.0% | 7.9% | 8.0% | · | 8.3% | |
| ROA | 2.3% | 2.3% | · | 2.5% | 2.4% | 2.2% | · | 1.8% | 2.1% | 1.9% | · | 1.2% | 1.3% | 1.2% | · | 1.4% | |
| ROE | 4.9% | 4.9% | · | 5.4% | 5.2% | 4.9% | · | 4.1% | 4.6% | 4.3% | · | 2.8% | 2.9% | 2.8% | · | 3.0% | |
| ROIC | 3.2% | 3.2% | · | 3.4% | 3.3% | 3.0% | · | 2.7% | 3.0% | 2.8% | · | 2.0% | 1.9% | 1.9% | · | 2.0% |
Płynność i wypłacalność
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.1 | 1.1 | · | 1.0 | 1.3 | 1.3 | · | 1.4 | 1.3 | 1.4 | · | 1.4 | 1.3 | 1.4 | · | 1.3 | |
| Quick Ratio | 0.9 | 0.9 | · | 0.9 | 1.1 | 1.1 | · | 1.2 | 1.1 | 1.2 | · | 1.2 | 1.1 | 1.1 | · | 1.0 | |
| Debt / Equity | 0.6 | 0.6 | · | 0.7 | 0.7 | 0.7 | · | 0.7 | 0.7 | 0.8 | · | 0.8 | 0.8 | 0.8 | · | 0.8 | |
| LT Debt / Equity | 0.5 | 0.5 | · | 0.6 | 0.6 | 0.7 | · | 0.7 | 0.7 | 0.8 | · | 0.8 | 0.8 | 0.8 | · | 0.8 | |
| Interest Coverage | 12.9 | 13.5 | · | 13.6 | 14.1 | 11.4 | · | 8.6 | 8.9 | 7.4 | · | 5.3 | 5.7 | 5.5 | · | 7.7 |
Efektywność
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.3 | 0.3 | · | 0.3 | 0.3 | 0.3 | · | 0.3 | 0.3 | 0.3 | · | 0.3 | 0.3 | 0.3 | · | 0.3 | |
| Receivables Turnover | 1.8 | 1.7 | · | 1.9 | 1.9 | 1.7 | · | 1.8 | 1.8 | 1.8 | · | 1.7 | 1.8 | 1.8 | · | 1.8 |
Na akcję
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue / Share | $77.42 | $72.89 | · | $70.61 | $65.91 | $62.08 | · | $58.19 | $57.53 | $56.13 | · | $51.17 | $50.09 | $48.51 | · | $45.66 | |
| Cash Flow / Share | · | $6.51 | · | · | · | $5.45 | · | · | · | $5.79 | · | · | · | $4.07 | · | · | |
| Dividend Paid / Share | $0.20 | $0.20 | $0.20 | $0.20 | $0.20 | $0.20 | $0.20 | $0.20 | $0.20 | $0.20 | $0.20 | $0.20 | $0.20 | $0.20 | $0.20 | $0.20 | |
| EPS (TTM) | $24.50 | $23.95 | · | $21.03 | $18.97 | $17.80 | · | $15.01 | $13.61 | $11.77 | · | $9.52 | $9.62 | $9.40 | · | $9.72 |
Wycena (TTM)
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $18.11B | $17.76B | · | $16.99B | $16.46B | $16.08B | · | $15.42B | $15.02B | $14.66B | · | $14.03B | $13.80B | $13.57B | · | $13.23B | |
| Net Income TTM | $1.53B | $1.52B | · | $1.38B | $1.26B | $1.20B | · | $1.03B | $934M | $817M | · | $676M | $692M | $685M | · | $740M | |
| P/E | 6.1 | 7.5 | · | 9.7 | 9.5 | 10.6 | · | 15.3 | 13.6 | 15.5 | · | 13.2 | 16.4 | 13.5 | · | 9.1 | |
| Earnings Yield | 16.5% | 13.4% | · | 10.3% | 10.5% | 9.5% | · | 6.6% | 7.4% | 6.5% | · | 7.6% | 6.1% | 7.4% | · | 11.0% | |
| Payout Ratio | · | 3.7% | · | · | · | 4.3% | · | · | · | 5.2% | · | · | · | 8.7% | · | · | |
| Annual Payout | $50M | $51M | · | $52M | $53M | $53M | · | $54M | $54M | $55M | · | $56M | $57M | $58M | · | $60M |
Najnowszy okres po lewej · wartości null pokazane jako ·
Sprawozdania finansowe Rachunek zysków i strat, bilans, przepływy pieniężne — roczne, ostatnie 5 lat
| Wskaźnik | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 |
|---|---|---|---|---|---|
| Przychody | $17.36B | $15.83B | $14.28B | · | · |
| Marża Operacyjna % | 11.5% | 10.6% | 8.2% | · | · |
| Zysk netto | $1.49B | $1.14B | $718M | · | · |
| Rozwodniony EPS | $23.10 | $16.82 | $10.23 | · | · |
| Wskaźnik | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 |
|---|---|---|---|---|---|
| Dług / Kapitał Własny | 0.7 | 0.7 | 0.8 | · | · |
| Wskaźnik bieżący | 1.1 | 1.3 | 1.4 | · | · |
| Wskaźnik Szybkości | 0.8 | 1.0 | 1.2 | · | · |
| Wskaźnik | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 |
|---|---|---|---|---|---|
| Wolny przepływ pieniężny | $849M | $1.12B | $525M | · | · |
Właściciele instytucjonalni (13F) 642 emitenci · $9.0B łącznie · Na dzień 30 września 2026
Instytucje, które zgłaszają posiadanie tych akcji w swoich kwartalnych zgłoszeniach SEC Form 13F. Tylko pozycje długie; pojedynczy zgłaszający może pojawić się dwukrotnie dla oddzielnych transz opcji. Duże przeciwstawne pozycje put/call zazwyczaj odzwierciedlają działalność market-makingową lub zabezpieczone zapasy, a nie przekonanie kierunkowe.
| Nowe pozycje | Zamknięte pozycje | Zwiększone | Zmniejszony | Zmiana liczby akcji netto |
|---|---|---|---|---|
| 73 (-10 vs poprzedni kw.) | 122 (+33 vs poprzedni kw.) | 215 (-37 vs poprzedni kw.) | 240 (+8 vs poprzedni kw.) | +2.4M |
Porównano z Q1 2026. Zgłoszenia SEC Form 13F są wymagane w ciągu 45 dni od końca kwartału plus krótki bufor dla spóźnionych zgłoszeń — kwartały mieszczące się jeszcze w tym terminie są pomijane na rzecz ostatniej w pełni zgłoszonej pary.
| Instytucja | Wartość | Akcje | % z śledzonych 13F | Typ |
|---|---|---|---|---|
| VANGUARD GROUP INC | $1 414 195 886 | 6 486 542 | 15,65% | Akcje |
| First Eagle Investment Management, LLC | $677 233 918 | 4 554 670 | 7,49% | Akcje |
| BlackRock, Inc. | $603 655 463 | 4 059 826 | 6,68% | Akcje |
| VANGUARD CAPITAL MANAGEMENT LLC | $504 386 069 | 3 392 199 | 5,58% | Akcje |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $364 614 198 | 2 452 177 | 4,03% | Akcje |
| DIMENSIONAL FUND ADVISORS LP | $328 686 665 | 2 210 595 | 3,64% | Akcje |
| STATE STREET CORP | $312 637 527 | 2 102 613 | 3,46% | Akcje |
| GEODE CAPITAL MANAGEMENT, LLC | $293 152 556 | 1 974 065 | 3,24% | Akcje |
| PZENA INVESTMENT MANAGEMENT LLC | $292 819 232 | 1 969 327 | 3,24% | Akcje |
| Invesco Ltd. | $290 116 048 | 1 951 147 | 3,21% | Akcje |
| FMR LLC | $210 657 318 | 1 416 755 | 2,33% | Akcje |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | $210 522 439 | 1 415 848 | 2,33% | Akcje |
| LOS ANGELES CAPITAL MANAGEMENT LLC | $158 819 352 | 1 068 124 | 1,76% | Akcje |
| AMERICAN CENTURY COMPANIES INC | $140 451 548 | 944 592 | 1,55% | Akcje |
| MASSACHUSETTS FINANCIAL SERVICES CO /MA/ | $135 479 763 | 906 103 | 1,50% | Akcje |
| NORGES BANK | $132 110 916 | 888 499 | 1,46% | Akcje |
| MORGAN STANLEY | $111 481 141 | 749 754 | 1,23% | Akcje |
| GOLDMAN SACHS GROUP INC | $89 504 438 | 601 953 | 0,99% | Akcje |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $85 524 258 | 575 185 | 0,95% | Akcje |
| CANADA PENSION PLAN INVESTMENT BOARD | $83 716 782 | 563 029 | 0,93% | Akcje |
| AQR CAPITAL MANAGEMENT LLC | $76 891 019 | 523 210 | 0,85% | Akcje |
| HOTCHKIS & WILEY CAPITAL MANAGEMENT LLC | $75 911 300 | 510 534 | 0,84% | Akcje |
| NORTHERN TRUST CORP | $67 032 574 | 450 821 | 0,74% | Akcje |
| Invenomic Capital Management LP | $63 529 884 | 427 264 | 0,70% | Akcje |
| MILLENNIUM MANAGEMENT LLC | $62 058 597 | 417 369 | 0,69% | Akcje |
| Qube Research & Technologies Ltd | $59 094 313 | 397 433 | 0,65% | Akcje |
| MACKENZIE FINANCIAL CORP | $56 636 764 | 380 905 | 0,63% | Akcje |
| Ranmore Fund Management Ltd | $56 501 159 | 379 993 | 0,63% | Akcje |
| Allianz Asset Management GmbH | $56 202 738 | 377 986 | 0,62% | Akcje |
| WORLDQUANT MILLENNIUM ADVISORS LLC | $52 580 501 | 353 625 | 0,58% | Akcje |
| UBS Group AG | $49 695 321 | 334 221 | 0,55% | Akcje |
| CITADEL ADVISORS LLC | $45 818 377 | 308 147 | 0,51% | Akcje |
| Quantinno Capital Management LP | $45 782 797 | 307 907 | 0,51% | Akcje |
| Bank of New York Mellon Corp | $44 605 741 | 299 992 | 0,49% | Akcje |
| NORDEA INVESTMENT MANAGEMENT AB | $44 371 846 | 300 663 | 0,49% | Akcje |
| VANGUARD FIDUCIARY TRUST CO | $44 081 678 | 296 467 | 0,49% | Akcje |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC | $42 437 187 | 237 119 | 0,47% | Akcje |
| Khrom Capital Management LLC | $39 401 958 | 264 994 | 0,44% | Akcje |
| Russell Investments Group, Ltd. | $37 642 835 | 253 289 | 0,42% | Akcje |
| Bridgewater Associates, LP | $33 919 311 | 228 121 | 0,38% | Akcje |
| SEI INVESTMENTS CO | $33 100 670 | 222 614 | 0,37% | Akcje |
| MOORE CAPITAL MANAGEMENT, LP | $33 071 927 | 222 422 | 0,37% | Akcje |
| Allspring Global Investments Holdings, LLC | $32 949 468 | 218 817 | 0,36% | Akcje |
| DEUTSCHE BANK AG\ | $31 202 151 | 209 847 | 0,35% | Akcje |
| FIRST TRUST ADVISORS LP | $31 057 609 | 208 876 | 0,34% | Akcje |
| CARRONADE CAPITAL MANAGEMENT, LP | $29 738 000 | 200 000 | 0,33% | Akcje |
| JPMORGAN CHASE & CO | $29 603 947 | 198 975 | 0,33% | Akcje |
| Arbejdsmarkedets Tillaegspension | $28 712 039 | 193 100 | 0,32% | Akcje |
| FRANKLIN RESOURCES INC | $28 049 718 | 188 646 | 0,31% | Akcje |
| BARCLAYS PLC | $27 758 340 | 186 686 | 0,31% | Akcje |
Insiderzy spółki 24 insiderów · 10 dyrektorzy generalni · 16 dyrektorzy
| Insider | Rola | Ostatnia aktywność | Posiadane akcje | Kupna 12m | Sprzedaże 12m | Netto 12m |
|---|---|---|---|---|---|---|
| Marc D Miller | President and CEO | 26 marca 2026 A | 388 621 | 0 | 0 | $0 |
| Steve Filton | Executive Vice President & CFO | 26 marca 2026 A | 144 715 | 0 | 0 | $0 |
| Alan B Miller | Executive Chairman | 27 maja 2026 J | 25 495 | 0 | 0 | $0 |
| Edward H Sim | Executive Vice President | 26 marca 2026 A | 24 790 | 0 | 0 | $0 |
| Matthew Jay Peterson | Executive Vice President, UHS | 26 marca 2026 A | 31 984 | 0 | 0 | $0 |
| Marvin G. Pember | Executive Vice President | 23 marca 2022 A | 36 599 | 0 | 0 | $0 |
| Debra K Osteen | Executive Vice President | 13 kwietnia 2018 A | 93 174 | 0 | 0 | $0 |
| Richard C Wright | Vice President | 26 listopada 2012 S | 0 | 0 | 0 | $0 |
| Michael Marquez | Senior Vice President | 4 czerwca 2010 M | 28 525 | 0 | 0 | $0 |
| Kevin J Gross | Senior Vice President | 31 maja 2007 M | 623 | 0 | 0 | $0 |
| Nina Chen-Langenmayr | Dyrektor | 20 maja 2026 A | 4 267 | 0 | 0 | $0 |
| Maria Ruderman Singer | Dyrektor | 20 maja 2026 A | 9 792 | 0 | 0 | $0 |
| Warren J. Nimetz | Dyrektor | 20 maja 2026 A | 9 698 | 0 | 2 | $-852 356 |
| Eileen C. Mcdonnell | Dyrektor | 20 maja 2026 A | 9 406 | 0 | 0 | $0 |
| Elliot J Md Mba Sussman | Dyrektor | 20 maja 2026 A | 7 330 | 0 | 3 | $-345 899 |
| Lawrence S. Gibbs | Dyrektor | 7 marca 2023 S | 2 230 | 0 | 0 | $0 |
| Robert H Hotz | Dyrektor | 29 lipca 2019 M | 52 715 | 0 | 0 | $0 |
| John H Herrell | Dyrektor | 15 maja 2018 M | 19 274 | 0 | 0 | $0 |
| Anthony Pantaleoni | Dyrektor | 29 listopada 2017 M | 1 794 | 0 | 0 | $0 |
| Leatrice Ducat | Dyrektor | 5 marca 2013 M | 4 000 | 0 | 0 | $0 |
| Richard J Santorum | Dyrektor | 16 maja 2011 M | 7 437 | 0 | 0 | $0 |
| Daniel B. Silvers | Dyrektor | 3 maja 2011 M | 2 048 | 0 | 0 | $0 |
| John F Williams JR | Dyrektor | 21 listopada 2008 A | 3 975 | 0 | 0 | $0 |
| Robert A Meister | Dyrektor | 21 listopada 2007 A | · | 0 | 0 | $0 |
Insiderzy z zgłoszeń SEC Form 3/4/5; netto = tylko otwarty rynek P/S
Posiadanie ETF-ów Posiadane przez 104 fundusze ETF
Waga odzwierciedla wyłącznie bezpośrednie udziały kapitałowe (N-PORT); fundusze oparte na dźwigni lub instrumentach pochodnych mogą posiadać dodatkowe ekspozycje na swapy, które nie są pokazane.
| Fundusz | Waga | Jednostki | Na dzień | Źródło |
|---|---|---|---|---|
| FXH · First Trust Exchange-Traded AlphaDE… | 2,57% | 159 598 NS | 31 lipca 2026 | N-PORT |
| LYLD · Cambria ETF Trust | 2,14% | 922 NS | 31 lipca 2026 | N-PORT |
| RSPH · Invesco Exchange-Traded Fund Trust | 1,64% | 81 839 SH | 2 października 2026 | Dziennie |
| CVSM · Elevation Series Trust | 1,59% | 8 938 NS | 31 lipca 2026 | N-PORT |
| SPGP · Invesco Exchange-Traded Fund Trust | 1,52% | 176 775 SH | 2 października 2026 | Dziennie |
| IHF · iShares Trust | 1,35% | 102 351 SH | 11 września 2026 | Dziennie |
| RNIN · EA Series Trust | 1,29% | 13 918 NS | 31 lipca 2026 | N-PORT |
| SYLD · Cambria ETF Trust | 1,09% | 64 307 NS | 31 lipca 2026 | N-PORT |
| SRHQ · Elevation Series Trust | 1,04% | 13 049 NS | 31 lipca 2026 | N-PORT |
| FCPI · FIDELITY COVINGTON TRUST | 0,95% | 15 263 NS | 31 lipca 2026 | N-PORT |
| FNK · First Trust Exchange-Traded AlphaDE… | 0,80% | 10 896 NS | 31 lipca 2026 | N-PORT |
| FDRR · FIDELITY COVINGTON TRUST | 0,54% | 23 720 NS | 31 lipca 2026 | N-PORT |
| FFSM · FIDELITY COVINGTON TRUST | 0,49% | 43 874 NS | 31 lipca 2026 | N-PORT |
| RPV · Invesco Exchange-Traded Fund Trust | 0,44% | 42 101 SH | 2 października 2026 | Dziennie |
| FNX · First Trust Exchange-Traded AlphaDE… | 0,42% | 34 637 NS | 31 lipca 2026 | N-PORT |
| DFAT · Dimensional ETF Trust | 0,40% | 345 907 NS | 31 lipca 2026 | N-PORT |
| PKW · Invesco Exchange-Traded Fund Trust | 0,31% | 29 880 SH | 2 października 2026 | Dziennie |
| DFSV · Dimensional ETF Trust | 0,31% | 151 188 NS | 31 lipca 2026 | N-PORT |
| JPUS · J.P. Morgan Exchange-Traded Fund Tr… | 0,28% | 7 534 NS | 31 lipca 2026 | N-PORT |
| JPME · J.P. Morgan Exchange-Traded Fund Tr… | 0,27% | 7 517 NS | 31 lipca 2026 | N-PORT |
| FAB · First Trust Exchange-Traded AlphaDE… | 0,24% | 2 408 NS | 31 lipca 2026 | N-PORT |
| RSP · Invesco Exchange-Traded Fund Trust | 0,20% | 1 110 425 SH | 2 października 2026 | Dziennie |
| BKMC · BNY Mellon ETF Trust | 0,20% | 7 667 NS | 31 lipca 2026 | N-PORT |
| BSCU · Invesco Exchange-Traded Self-Indexe… | 0,19% | 5 968 000 | 2 października 2026 | Dziennie |
| BBMC · J.P. Morgan Exchange-Traded Fund Tr… | 0,19% | 22 463 NS | 31 lipca 2026 | N-PORT |
| FSMD · FIDELITY COVINGTON TRUST | 0,18% | 27 092 NS | 31 lipca 2026 | N-PORT |
| FDVV · FIDELITY COVINGTON TRUST | 0,18% | 107 089 NS | 31 lipca 2026 | N-PORT |
| VBR · VANGUARD INDEX FUNDS | 0,16% | 737 146 SH | 19 sierpnia 2026 | Dziennie |
| PFIG · Invesco Exchange-Traded Fund Trust … | 0,16% | 220 000 | 2 października 2026 | Dziennie |
| JVAL · J.P. Morgan Exchange-Traded Fund Tr… | 0,15% | 7 588 NS | 31 lipca 2026 | N-PORT |
| VFVA · VANGUARD WELLINGTON FUND | 0,15% | 8 469 SH | 19 sierpnia 2026 | Dziennie |
| IYH · iShares Trust | 0,14% | 29 765 SH | 11 września 2026 | Dziennie |
| FHLC · FIDELITY COVINGTON TRUST | 0,12% | 24 277 NS | 31 lipca 2026 | N-PORT |
| SMMD · iShares Trust | 0,12% | 27 226 SH | 11 września 2026 | Dziennie |
| LGDX · Tidal Trust III | 0,12% | 1 016 NS | 31 lipca 2026 | N-PORT |
| IXJ · iShares Trust | 0,12% | 28 234 SH | 11 września 2026 | Dziennie |
| DFAS · Dimensional ETF Trust | 0,12% | 105 486 NS | 31 lipca 2026 | N-PORT |
| BSCT · Invesco Exchange-Traded Self-Indexe… | 0,11% | 3 422 000 | 2 października 2026 | Dziennie |
| NFRA · FlexShares Trust | 0,11% | 20 262 NS | 31 lipca 2026 | N-PORT |
| VHT · VANGUARD WORLD FUND | 0,11% | 153 595 SH | 19 sierpnia 2026 | Dziennie |
| GLOF · iShares Trust | 0,11% | 1 247 SH | 11 września 2026 | Dziennie |
| CURE · Direxion Shares ETF Trust | 0,10% | 1 049 NS | 31 lipca 2026 | N-PORT |
| EQAL · Invesco Exchange-Traded Fund Trust … | 0,10% | 4 377 SH | 2 października 2026 | Dziennie |
| DXUV · Dimensional ETF Trust | 0,09% | 3 027 NS | 31 lipca 2026 | N-PORT |
| RWL · Invesco Exchange-Traded Fund Trust … | 0,09% | 51 324 SH | 2 października 2026 | Dziennie |
| VB · VANGUARD INDEX FUNDS | 0,09% | 1 161 113 SH | 19 sierpnia 2026 | Dziennie |
| IWS · iShares Trust | 0,09% | 75 629 SH | 11 września 2026 | Dziennie |
| WSML · iShares Trust | 0,08% | 3 240 SH | 11 września 2026 | Dziennie |
| TILT · FlexShares Trust | 0,08% | 9 796 NS | 31 lipca 2026 | N-PORT |
| IUS · Invesco Exchange-Traded Self-Indexe… | 0,07% | 4 082 SH | 2 października 2026 | Dziennie |
| RECS · Columbia ETF Trust I | 0,07% | 25 532 NS | 31 lipca 2026 | N-PORT |
| IWR · iShares Trust | 0,06% | 208 577 SH | 11 września 2026 | Dziennie |
| DFUV · Dimensional ETF Trust | 0,06% | 53 251 NS | 31 lipca 2026 | N-PORT |
| XOEF · iShares Trust | 0,05% | 67 SH | 11 września 2026 | Dziennie |
| PRF · Invesco Exchange-Traded Fund Trust | 0,05% | 28 658 SH | 2 października 2026 | Dziennie |
| DFAC · Dimensional ETF Trust | 0,04% | 107 516 NS | 31 lipca 2026 | N-PORT |
| IVE · iShares Trust | 0,03% | 88 425 SH | 11 września 2026 | Dziennie |
| VOOV · VANGUARD ADMIRAL FUNDS | 0,03% | 12 323 SH | 19 sierpnia 2026 | Dziennie |
| IUSV · iShares Trust | 0,03% | 46 100 SH | 11 września 2026 | Dziennie |
| DCOR · Dimensional ETF Trust | 0,03% | 5 685 NS | 31 lipca 2026 | N-PORT |
| IWD · iShares Trust | 0,02% | 112 974 SH | 11 września 2026 | Dziennie |
| EGLE · Global X Funds | 0,02% | 3 NS | 31 lipca 2026 | N-PORT |
| VONV · VANGUARD SCOTTSDALE FUNDS | 0,02% | 30 745 SH | 19 sierpnia 2026 | Dziennie |
| DYNF · BlackRock ETF Trust | 0,02% | 45 056 SH | 11 września 2026 | Dziennie |
| TOPC · iShares Trust | 0,02% | 33 SH | 11 września 2026 | Dziennie |
| XVV · iShares Trust | 0,02% | 647 SH | 11 września 2026 | Dziennie |
| DFAU · Dimensional ETF Trust | 0,02% | 11 778 NS | 31 lipca 2026 | N-PORT |
| XYLG · Global X Funds | 0,02% | 58 NS | 31 lipca 2026 | N-PORT |
| XYLD · Global X Funds | 0,02% | 2 904 NS | 31 lipca 2026 | N-PORT |
| XRMI · Global X Funds | 0,01% | 44 NS | 31 lipca 2026 | N-PORT |
| PTLC · Pacer Funds Trust | 0,01% | 2 808 NS | 31 lipca 2026 | N-PORT |
| XCLR · Global X Funds | 0,01% | 3 NS | 31 lipca 2026 | N-PORT |
| IVV · iShares Trust | 0,01% | 671 648 SH | 11 września 2026 | Dziennie |
| PBP · Invesco Exchange-Traded Fund Trust | 0,01% | 308 SH | 1 października 2026 | Dziennie |
| OMFL · Invesco Exchange-Traded Self-Indexe… | 0,01% | 3 713 SH | 2 października 2026 | Dziennie |
| IWB · iShares Trust | 0,01% | 36 488 SH | 11 września 2026 | Dziennie |
| IYY · iShares Trust | 0,01% | 2 238 SH | 11 września 2026 | Dziennie |
| SPUU · Direxion Shares ETF Trust | 0,01% | 201 NS | 31 lipca 2026 | N-PORT |
| IWV · iShares Trust | 0,01% | 14 744 SH | 11 września 2026 | Dziennie |
| QDPL · Pacer Funds Trust | 0,01% | 1 283 NS | 31 lipca 2026 | N-PORT |
| ITOT · iShares Trust | 0,01% | 68 363 SH | 11 września 2026 | Dziennie |
| DFUS · Dimensional ETF Trust | 0,01% | 14 968 NS | 31 lipca 2026 | N-PORT |
| PHDG · Invesco Actively Managed Exchange-T… | 0,01% | 42 SH | 2 października 2026 | Dziennie |
| HCMT · Direxion Shares ETF Trust | 0,01% | 369 NS | 31 lipca 2026 | N-PORT |
| XTR · Global X Funds | 0,01% | 3 NS | 31 lipca 2026 | N-PORT |
| SPXL · Direxion Shares ETF Trust | 0,01% | 4 165 NS | 31 lipca 2026 | N-PORT |
| VOO · VANGUARD INDEX FUNDS | 0,01% | 1 383 774 SH | 19 sierpnia 2026 | Dziennie |
| VTI · VANGUARD INDEX FUNDS | 0,01% | 1 606 967 SH | 19 sierpnia 2026 | Dziennie |
| VT · VANGUARD INTERNATIONAL EQUITY INDEX… | 0,01% | 41 234 SH | 19 sierpnia 2026 | Dziennie |
| VONE · VANGUARD SCOTTSDALE FUNDS | 0,01% | 8 402 SH | 19 sierpnia 2026 | Dziennie |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,01% | 4 280 SH | 19 sierpnia 2026 | Dziennie |
| ESGV · VANGUARD WORLD FUND | 0,01% | 11 510 SH | 19 sierpnia 2026 | Dziennie |
| QVML · Invesco Exchange-Traded Fund Trust … | 0,01% | 882 SH | 2 października 2026 | Dziennie |
| DFLV · Dimensional ETF Trust | 0,00% | 636 NS | 31 lipca 2026 | N-PORT |
| GTO · Invesco Actively Managed Exchange-T… | 0,00% | 3 000 | 30 września 2026 | Dziennie |
| BSV · VANGUARD BOND INDEX FUNDS | · | · | 15 lipca 2026 | Dziennie |
| BND · VANGUARD BOND INDEX FUNDS | · | · | 15 lipca 2026 | Dziennie |
| VCSH · VANGUARD SCOTTSDALE FUNDS | · | · | 15 lipca 2026 | Dziennie |
| VCIT · VANGUARD SCOTTSDALE FUNDS | · | · | 15 lipca 2026 | Dziennie |
| VTC · VANGUARD SCOTTSDALE FUNDS | · | · | 30 lipca 2026 | Dziennie |
| BNDW · VANGUARD SCOTTSDALE FUNDS | · | · | 30 lipca 2026 | Dziennie |
| ISCB · iShares Trust | · | 2 307 SH | 11 września 2026 | Dziennie |
| ISCV · iShares Trust | · | 11 393 SH | 11 września 2026 | Dziennie |
| SMMV · iShares Trust | · | 2 436 SH | 1 września 2026 | Dziennie |
UHS Konsensus analityków Bycze i niedźwiedzie opinie analityków, 12-miesięczny cel cenowy, potencjał wzrostu
12-miesięczny cel cenowy
17 analityków · 2026-10-04Średnia cel $194.35 +10,6%
Porównanie z porównywalnymi firmami (podbranża GICS) Kluczowe metryki w porównaniu do konkurentów z sektora
Podstawa R/R, ceny według zamknięcia z ostatniego końca roku obrotowego każdej spółki.
| Ticker | Kapitalizacja Rynkowa | P/E | Przychody r/r | Marża Netto | ROE | Marża brutto |
|---|---|---|---|---|---|---|
| UHS | · | 9.4 | 9.7% | 8.6% | 21.4% | · |
| HCA | $104.86B | 16.5 | 7.1% | 9.0% | -159.1% | · |
| THC | $17.28B | 12.8 | 3.1% | 11.1% | 56.4% | · |
| EHC | $10.61B | 19.2 | 10.5% | 9.5% | 25.1% | · |
| ENSG | $10.12B | 29.8 | 18.7% | 6.8% | 16.9% | · |
| PACS | $6.01B | 31.5 | 29.3% | 3.6% | 23.1% | · |
| CON | $2.53B | 15.1 | 13.9% | 7.7% | 49.8% | · |
| ACHC | $1.28B | -1.2 | 5.0% | -33.3% | -43.9% | · |
| BKD | $2.57B | -9.6 | 2.2% | -8.2% | -313.2% | 26.2% |
| SNDA | $612M | -7.7 | 25.2% | -18.6% | -197.2% | · |
Najnowsze wiadomości Najnowsze nagłówki wspominające o tej firmie
Moje wskaźniki Twoja osobista lista obserwowanych — wybrane wiersze z Pełnych Fundamentów
Wybierz wskaźniki, które są dla Ciebie ważne — kliknij + obok dowolnego wiersza w sekcji Pełne dane fundamentalne powyżej.
Twój wybór został zapisany i będzie Ci towarzyszył we wszystkich tickerach.